Physician profile
Whitney M Wright
NPI 1831478361
$6,038.88
in general payments reported to CMS, 2019-2025
25 companies · $1,133 in 2025
The $1,133 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,190 · 2022: $1,324 · 2023: $1,312 · 2024: $1,080 · 2025: $1,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,525.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,134.63 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $646.29 | 2021-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $623.35 | 2021-2024 | Xarelto |
| Pfizer INC. | $525.37 | 2021-2025 | |
| Esperion Therapeutics, INC. | $454.43 | 2021-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $419.09 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $403.99 | 2021-2025 | Brilinta, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $403.57 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $335.50 | 2021-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $248.42 | 2021-2025 | Lifevest |
| Abiomed | $168.05 | 2025 | |
| Amarin Pharma, INC. | $148.07 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.40 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $66.26 | 2025 | Assure Wcd |
| Scpharmaceuticals INC. | $60.61 | 2023-2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $57.21 | 2022-2024 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Actelion Pharmaceuticals US, INC. | $46.76 | 2024 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $45.30 | 2021 | |
| Novo Nordisk INC | $44.28 | 2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $31.08 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $29.99 | 2024 | Arcalyst |
| Abbott Laboratories | $24.95 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $20.33 | 2024 | Linq II |
| Philips North America LLC | $15.56 | 2023 | |
| Medicomp INC | $13.39 | 2024 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.